Myofibroblasts are absent from normal tissues.
|
|
- Jessie Thompson
- 5 years ago
- Views:
Transcription
1 AMERICAN ASSOCIATION FOR THE STUDY OFLIVERD I S E ASES CONCISE REVIEW HEPATOLOGY, VOL. 65, NO. 3, 2017 The Origin of Fibrogenic Myofibroblasts in Fibrotic Liver Tatiana Kisseleva Liver fibrosis results from chronic liver injury of different etiologies. It is characterized by dysregulation of physiological remodeling, activation of myofibroblasts, and formation of a fibrous scar. Myofibroblasts develop contractile functions and secrete the extracellular matrix proteins that form this fibrous scar. Myofibroblasts are not present in the normal liver but activate and proliferate in response to injury and inflammation. This review summarizes the understanding and controversies on the contribution of cell populations to the myofibroblasts in liver fibrosis. (HEPATOLOGY 2017;65: ). Myofibroblasts are absent from normal tissues. During normal tissue repair, transient activation of myofibroblasts contributes to restoration of integrity of the tissue by forming a mechanical scar that is usually dissolved when the tissue is repaired. At this stage myofibroblasts are cleared by apoptosis or by inactivation. (1,2) In contrast, persistent myofibroblast activation causes accumulation and contraction of collagenous extracellular matrix (ECM), a condition called fibrosis. Myofibroblasts are defined by de novo development of stress fibers and contractual forces and the secretion of ECM proteins forming a fibrous scar. The most widely used marker of myofibroblasts in research and clinical diagnostics is the de novo expression of alpha smooth muscle actin. Other useful markers of myofibroblasts are F-actin, vinculin, and extra domain A containing fibronectin. The activation process describes newly acquired cell contraction, migration, proliferation, cytokine production, ECM secretion, and ECM degradation. (2) Myofibroblasts are the source of the fiber scar in the kidney, lung, and liver. Myofibroblasts are a heterogeneous population of cells. The origin of myofibroblasts depends on the tissue that is injured and the type of injury of a specific tissue. The proposed sources of myofibroblasts in liver fibrosis are epithelial cells, mesenchymal stromal cells (MSCs), fibrocytes, mesothelial cells, hepatic stellate cells (HSCs), and portal fibroblasts (PFs). Although advanced genetic techniques have provided strong evidence that HSCs are the predominant source of myofibroblasts in many types of experimental liver injury, some controversies remain. These include the contribution of recruited fibrocytes to the myofibroblast population, the contribution of PFs/myofibroblasts to early cholestatic liver injury, and a possible role for mesothelial cells in capsular or intrahepatic liver fibrosis (see Fig. 1). In general, three methods have been used to trace the origin of myofibroblasts in the liver. Probably the best-validated method is the use of inducible genetic tracing studies in which the purported precursor cell is inducibly marked, such as using a cell-specific inducible cyclization recombination (Cre; CreERT2) crossed with a floxed reporter gene (such as green fluorescent protein [GFP]) and then inducing a prototypical liver injury in a mouse to induce fibrosis. If the resulting myofibroblast cells, which are identified by the markers discussed above, also express the reporter gene expressed in the precursor cell, then the logical conclusion is that the myofibroblasts originated from the precursor cell population. However, this fatetracing approach is only available for a limited number Abbreviations: BDL, bile duct ligation; BM, bone marrow; Cre, cyclization recombination; ECM, extracellular matrix; GFP, green fluorescent protein; HSC, hepatic stellate cell; LRAT, lecithin retinol acyl-transferase; MSC, mesenchymal stromal cell; PF, portal fibroblast. Received February 8, 2016; accepted November 8, Supported by the National Institutes of Health (AA022614, DK099205, DK101737). Copyright VC 2016 by the American Association for the Study of Liver Diseases. View this article online at wileyonlinelibrary.com. DOI /hep Potential conflict of interest: Nothing to report. 1039
2 KISSELEVA HEPATOLOGY, March 2017 FIG. 1. Specific markers of activated HSCs, quiescent HSCs, and inactivated HSCs, activated PFs, fibrocytes, and mesothelial cells (explanations are in the text). Abbreviations: ahsc, activated HSC; asma, alpha smooth muscle actin; CCR, chemokine (C-C motif) receptor; CD, cluster of differentiation; Col1a1, collagen type 1a1; GFAP, glial fibrillary acidic protein; ihsc, inactivated HSC; MHC-II, major histocompatibility complex II; PPAR, peroxisome proliferator activated receptor; qhsc, quiescent HSC. of cell types, such as for cholangiocytes. Tamoxifen, the most widely used agent to induce CRE expression, may give false-positive results by modifying liver cell physiology. An alternative approach has been to identify myofibroblasts using established myofibroblast markers or genetic reporter genes (such as type 1 collagen-gfp or alpha smooth muscle actin GFP) (3) and then to analyze the heterogeneous myofibroblast population to identify markers consistent with their precursor origin. Using immunohistochemistry of fibrotic liver and fluorescence-activated cell sorting of liver cell preparations, many markers have been identified for cell populations that may potentially become myofibroblasts (Fig. 1). The limitation of this approach is that genetic markers may be acquired or lost during activation, creating a false impression of the cell of origin. The third approach used to assess whether the bone marrow (BM) is the source for myofibroblasts is the most robust and conceptually the simplest. With this approach mice undergo lethal irradiation, followed by BM transplant with genetically marked cells (such as type 1 collagen GFP). The BM chimeric mouse ARTICLE INFORMATION: From the Department of Surgery, University of California San Diego, San Diego, CA. ADDRESS CORRESPONDENCE AND REPRINT REQUESTS TO: Tatiana Kisseleva, M.D., Ph.D Gilman Drive #0063 La Jolla, California, tkisseleva@ucsd.edu Tel:
3 HEPATOLOGY, Vol. 65, No. 3, 2017 KISSELEVA then is subjected to liver injury (e.g., CCl 4 gavage, bile duct ligation [BDL]) so that any BM-derived myofibroblasts are readily identified. Epithelial Mesenchymal Transition Epithelial mesenchymal transition is a process in which parenchymal cells (epithelial cells) become myofibroblasts. Studies that supported this concept were based on an overlap of cells that expressed markers for epithelial cells and myofibroblasts (for example, expressing both cytokeratin 19 and type 1 collagen) and of transforming growth factor b induced conversion of parenchymal cells to fibroblast-like cells in culture. (4-6) However, lineage-tracing experiments that permanently mark cholangiocytes (K19), hepatocytes (albumin), or epithelial precursor cells (alpha-fetoprotein) have clearly demonstrated that myofibroblasts induced in liver fibrosis injury models are not derived from epithelial cells. However, epithelial cells such as cholangiocytes and hepatocytes change their gene expression profiles during liver injury and express some mesenchymal markers. This is most clearly demonstrated in the role of de novo snail expression in hepatocytes during CCl 4 -induced liver fibrosis. (7) Because parenchymal cells from fibrotic liver do not express all myofibroblast markers or secrete ECM proteins, perhaps the concept of partial epithelial mesenchymal transition should be ascribed to this change in gene expression. BM-Derived Cells There are two potential BM sources of myofibroblasts, mesenchymal stem cells and fibrocytes. MSCs (also called mesenchymal stem cells ) are found in many tissues, including adipose tissue and BM. As alleged mesenchymal stem cells, MSCs have been proposed as a source of myofibroblasts in injured tissues to which they are recruited. More recent studies using MSCs have demonstrated that they are actually shortlived in the recruited tissue, are antifibrotic when added to injured tissue, and may actually provide a protective microenvironment, perhaps through immunosuppression. (8) Current clinical trials are assessing the role of MSCs as therapy for liver fibrosis. Fibrocytes are defined as CD34 1 type 1 collagen 1 cells. They are myeloid cells derived in the BM and then recruited to different sites of injury. In the injured tissue they may differentiate into macrophages or myofibroblasts. Studies in liver report a range of respective fibrocyte contributions to myofibroblasts of between 3% and 50%. (9,10) Nonetheless, most studies do not reveal a significant contribution of fibrocytes to the myofibroblast population in fibrotic liver disease. Importantly, many studies performed with the genetic lineage-tracing approach account for nearly all of the myofibroblasts coming from sources other than the BM, so their quantitative contribution to myofibroblasts should be small. (11,12) Mesothelial Cells Cell fate mapping experiments using mesothelin, Msx2 (msh-like 2), or Wilms tumor 1 homolog as markers have provided strong evidence that epithelial mesothelial cells are the origin of both PFs and HSCs during embryonic development. (13,14) Whether mesothelial cells, the epithelial cells lining the peritoneum and other body cavities, can be a source of myofibroblasts in liver fibrosis is unclear. A recent study used fluorescent-activated cell sorting to purify three different populations of cells. Mesothelial cells, identified by the mesothelial cell marker GPM6, did not express type 1 collagen mrna. Therefore, these cells designated as originating from mesothelial cells are not the source of myofibroblasts in the BDL experimental model. (15) However, mesothelial cells may contribute to fibrosis of the liver capsule, (10) a common finding in cirrhosis, and the peritoneum. Perhaps some of the confusion about the relative contribution of HSCs, PFs, and mesothelial cells may result from the fact that the three cell types probably all originate from the same cell during development and may express common markers. HSCs Genetic cell fate mapping using platelet-derived growth factor receptor a, (16) glial fibrillar acidic protein, (17) and lecithin retinol acyl-transferase (LRAT) (11) have all provided strong evidence that the predominant cell of origin of myofibroblasts in most types of experimental liver disease are the HSCs. While quiescent HSCs are present in the uninjured liver as the vitamin A lipid droplet containing cells in the space of Disse, activated HSCs maintain most of their quiescent markers and acquire a myofibroblast phenotype. However, because none of these quiescent markers are 1041
4 KISSELEVA HEPATOLOGY, March 2017 inducible, a pulse-chase experiment cannot be performed and they do not fulfill the classic experimental design for cell fate mapping. LratCre may not provide an inducible fate-tracing approach and might possibly label additional cells in the course of fibrogenesis. All LratCre-labeled cells in the liver contained vitamin A following cholestatic liver injury, whereas LratCrenegative PF-like cells did not contain vitamin A. This suggests that LratCre labels vitamin A 1 HSCs. (11) However, an independent second method also demonstrated that HSCs are the predominant cells that become myofibroblasts throughout the response to toxic liver injury. PFs are a major source of myofibroblasts during early cholestatic injury, but HSCs become the predominant source as the injury progresses (12) (see below). PFs PFs are believed to be a local quiescent fibroblast population. Because there are no known single markers to discriminate fibroblasts from other mesenchymal cells, it is difficult to identify or purify quiescent PFs. Activated PFs were first described in clinical and experimental cholestatic liver disease by histology, immunohistochemistry, electron microscopy, and immunoelectron microscopy (18-20) that clearly distinguished two cell populations. Further descriptions identified markers that were positive on PFs but not on HSCs, including elastin, Thy1, and Ntpdase2 (21) (see Fig. 1). The experimental studies emphasized the contribution of PFs to fibrosis during the early onset of the cholestatic injury, which is consistent with the later studies using genetically marked cells. (12) However, there are no established methods to use inducible cell-specific markers to do pulse labeling to establish a genetic lineage tracing for PFs. Although PFs are reported to be rare in normal liver, they have been purified in rat liver. (21) A marker, Ntpdase2, has been reported for quiescent activated fibroblasts but not for myofibroblasts. In cholestatic injury (BDL), two studies have generated similar results using the same type 1 collagen GFP reporter mouse. (12,15) In each case, two distinct populations of type 1 collagen mrna positive cells consistent with myofibroblasts were identified as HSCs and PFs. The experimental error in quantifying the contribution of HSCs and PFs could mask a minor contribution of other cell types such as fibrocytes to cholestatic liver injury. Differences in the proposed contribution of PFs to the myofibroblast population in BDL may reflect differences in fibrotic time course in different mouse strains, different microbiota, and other differences in mouse house environment as well as the above-discussed limitations of the different types of methodologies for assessing this quantification. Conclusions Fibrogenic hepatic myofibroblasts arise mostly from liver-resident HSCs, activated PFs, and mesothelial cells. Activated HSCs are the predominant contributor to myofibroblasts during toxic liver injury and late cholestatic injury, while activated PFs contribute to early cholestatic injury. BM-derived fibrocytes make a quantitatively small contribution to liver fibrosis; they migrate to the fibrosing liver in response to both cholestatic and toxic liver injury. Identifying the origin of myofibroblasts in different fibrotic diseases will lead to a greater understanding of the pathophysiology of fibrosis, provide new insights into the regression of fibrosis, and lead to more targeted therapy of fibrosis. REFERENCES 1) Hinz B, Phan SH, Thannickal VJ, Prunotto M, Desmouliere A, Varga J, et al. Recent developments in myofibroblast biology: paradigms for connective tissue remodeling. Am J Pathol 2012; 180: ) Hinz B. Myofibroblasts. Exp Eye Res 2016;142: ) Magness ST, Bataller R, Yang L, Brenner DA. A dual reporter gene transgenic mouse demonstrates heterogeneity in hepatic fibrogenic cell populations. HEPATOLOGY 2004;40: ) Scholten D, Osterreicher CH, Scholten A, Iwaisako K, Gu G, Brenner DA, et al. Genetic labeling does not detect epithelialto-mesenchymal transition of cholangiocytes in liver fibrosis in mice. Gastroenterology 2010;139: ) Taura K, Miura K, Iwaisako K, Osterreicher CH, Kodama Y, Penz- Osterreicher M, et al. Hepatocytes do not undergo epithelialmesenchymal transition in liver fibrosis in mice. HEPATOLOGY 2010; 51: ) Chu AS, Diaz R, Hui JJ, Yanger K, Zong Y, Alpini G, et al. Lineage tracing demonstrates no evidence of cholangiocyte epithelial-to-mesenchymal transition in murine models of hepatic fibrosis. HEPATOLOGY 2011;53: ) Rowe RG, Lin Y, Shimizu-Hirota R, Hanada S, Neilson EG, Greenson JK, et al. Hepatocyte-derived Snail1 propagates liver fibrosis progression. Mol Cell Biol 2011;31: ) Prockop DJ. Inflammation, fibrosis, and modulation of the process by mesenchymal stem/stromal cells. Matrix Biol 2016;51: ) Kisseleva T, Uchinami H, Feirt N, Quintana-Bustamante O, Segovia JC, Schwabe RF, et al. Bone marrow-derived fibrocytes participate in pathogenesis of liver fibrosis. J Hepatol 2006;45:
5 HEPATOLOGY, Vol. 65, No. 3, 2017 KISSELEVA 10) Lua I, Li Y, Pappoe LS, Asahina K. Myofibroblastic conversion and regeneration of mesothelial cells in peritoneal and liver fibrosis. Am J Pathol 2015;185: ) Mederacke I, Hsu CC, Troeger JS, Huebener P, Mu X, Dapito DH, et al. Fate tracing reveals hepatic stellate cells as dominant contributors to liver fibrosis independent of its aetiology. Nat Commun 2013;4: ) Iwaisako K, Jiang C, Zhang M, Cong M, Moore-Morris TJ, Park TJ, et al. Origin of myofibroblasts in the fibrotic liver in mice. Proc Natl Acad Sci USA 2014;111:E3297- E ) Rinkevich Y, Mori T, Sahoo D, Xu PX, Bermingham JR Jr, Weissman IL. Identification and prospective isolation of a mesothelial precursor lineage giving rise to smooth muscle cells and fibroblasts for mammalian internal organs, and their vasculature. Nat Cell Biol 2012;14: ) Asahina K, Zhou B, Pu WT, Tsukamoto H. Septum transversum-derived mesothelium gives rise to hepatic stellate cells and perivascular mesenchymal cells in developing mouse liver. HEPATOLOGY 2011;53: ) Lua I, Li Y, Zagory JA, Wang KS, French SW, Sevigny J, et al. Characterization of hepatic stellate cells, portal fibroblasts, and mesothelial cells in normal and fibrotic livers. J Hepatol ) Henderson NC, Arnold TD, Katamura Y, Giacomini MM, Rodriguez JD, McCarty JH, et al. Targeting of alphav integrin identifies a core molecular pathway that regulates fibrosis in several organs. Nat Med 2013;19: ) Puche JE, Lee YA, Jiao J, Aloman C, Fiel MI, Munoz U, et al. A novel murine model to deplete hepatic stellate cells uncovers their role in amplifying liver damage in mice. HEPATOLOGY 2013;57: ) Tang L, Tanaka Y, Marumo F, Sato C. Phenotypic change in portal fibroblasts in biliary fibrosis. Liver 1994;14: ) Herbst H, Frey A, Heinrichs O, Milani S, Bechstein WO, Neuhaus P, et al. Heterogeneity of liver cells expressing procollagen types I and IV in vivo. Histochem Cell Biol 1997;107: ) Cassiman D, Libbrecht L, Desmet V, Denef C, Roskams T. Hepatic stellate cell/myofibroblast subpopulations in fibrotic human and rat livers. J Hepatol 2002;36: ) Fausther M, Goree JR, Lavoie EG, Graham AL, Sevigny J, Dranoff JA. Establishment and characterization of rat portal myofibroblast cell lines. PLoS One 2015;10:e
Portal Fibroblasts in Biliary Fibrosis
Curr Pathobiol Rep (2014) 2:185 190 DOI 10.1007/s40139-014-0054-y MYOFIBROBLAST (TATIANA KISSELEVA, SECTION EDITOR) Portal Fibroblasts in Biliary Fibrosis Rebecca G. Wells Published online: 14 September
More informationMechanisms of hepatic fibrogenesis in chronic liver disease
Mechanisms of hepatic fibrogenesis in chronic liver disease JPEMS 2014, Physiopathology Module Corentin Bessy (Nantes) _ Gabrielle Cepella (Amsterdam) _ Charly Gaisne (Angers) _ Gwladys Guilloineau (Angers)
More informationNottingham Patterns of liver fibrosis and their clinical significance
Nottingham 2006 Patterns of liver fibrosis and their clinical significance Alastair D Burt Professor of Pathology and Dean of Clinical Medicine University of Newcastle upon Tyne Collapse of reticulin
More informationTissue renewal and Repair. Nisamanee Charoenchon, PhD Department of Pathobiology, Faculty of Science
Tissue renewal and Repair Nisamanee Charoenchon, PhD Email: nisamanee.cha@mahidol.ac.th Department of Pathobiology, Faculty of Science Topic Objectives 1. Describe processes of tissue repair, regeneration
More informationEMT in Liver Fibrosis
Curr Pathobiol Rep (2014) 2:201 207 DOI 10.1007/s40139-014-0056-9 MYOFIBROBLAST (TATIANA KISSELEVA, SECTION EDITOR) EMT in Liver Fibrosis V. Sterzer M. Alsamman T. Bretag D. Scholten Published online:
More informationLaura Smart 9/22/2011
Laura Smart 9/22/2011 Fibrosis is a wound healing response in which damaged regions are encapsulated by an extracellular matrix or scar. Fibrosis develops in almost all patients with chronic liver injury
More informationUnderstanding Root Cause: Pathogenesis of Hepatic Fibrosis
10/1/12 Understanding Root Cause: Pathogenesis of Hepatic Fibrosis Hepatitis C Virus Mild inflammation Inflammation Fibrosis Cirrhosis 1 10/1/12 Non-alcoholic Fatty Liver Disease Steatosis Steatohepatitis
More informationMesothelin/mucin 16 signaling in activated portal fibroblasts regulates cholestatic liver fibrosis
Mesothelin/mucin 16 signaling in activated portal fibroblasts regulates cholestatic liver fibrosis Yukinori Koyama,, David A. Brenner, Tatiana Kisseleva J Clin Invest. 2017;127(4):1254-1270. https://doi.org/10.1172/jci88845.
More informationvi Preface Table 2 Association of Fibrosis With Types of Injury: Representative Examples
Fibrosis or scar, defined pathologically as inappropriate repair by connective tissue, is increasingly recognized as an important feature of many chronic diseases (Table 1), and as such, represents an
More informationImmunological Lung Diseases
Emphysema and Fibrosis Universitätsklinik für Pneumologie Prof. Thomas Geiser Head Div. of Pulmonary Medicine and Laboratory of Lung Research, MU50 thomas.geiser@insel.ch The healthy lung: The pathway
More informationReviewers' comments: Reviewer #1 (Remarks to the Author):
Reviewers' comments: Reviewer #1 (Remarks to the Author): The manuscript by Wu et al describes critical role of RNA binding protein CUGBP1 in the development of TGF-beta-mediated liver fibrosis. The activation
More informationThe Role of Fibrocytes in Fibrogenic Liver Diseases
Curr Pathobiol Rep (2014) 2:191 199 DOI 10.1007/s40139-014-0055-x MYOFIBROBLAST (TATIANA KISSELEVA, SECTION EDITOR) The Role of Fibrocytes in Fibrogenic Liver Diseases Min Cong Jidong Jia Published online:
More informationRole of Inflammatory and Progenitor Cells in Pulmonary Vascular Remodeling: Potential Role for Targeted Therapies. Traditional Hypothesis Stress
3/1/212 Role of Inflammatory and Progenitor Cells in Pulmonary Vascular Remodeling: Potential Role for Targeted Therapies K.R. Stenmark University of Colorado Denver, CO 845 Prominent Fibroproliferative
More informationLiver Fibrosis: Which Mechanisms Matter?
REVIEW Liver Fibrosis: Which Mechanisms Matter? Ralf Weiskirchen, Ph.D.,* and Frank Tacke, M.D., Ph.D. HEPATIC FIBROSIS Historically, fibrosis was defined by a World Health Organization expert group in
More informationHealing & Repair. Tissue Regeneration
Healing & Repair Dr. Srikumar Chakravarthi Repair & Healing: Are they same? Repair :Regeneration of injured cells by cells of same type, as with regeneration of skin/oral mucosa (requires basement membrane)
More informationLiver fibrosis is the consequence of a sustained. Hepatocytes Do Not Undergo Epithelial-Mesenchymal Transition in Liver Fibrosis in Mice
LIVER BIOLOGY/PATHOBIOLOGY Hepatocytes Do Not Undergo Epithelial-Mesenchymal Transition in Liver Fibrosis in Mice Kojiro Taura,* Kouichi Miura,* Keiko Iwaisako, Christoph H. Österreicher, Yuzo Kodama,
More informationMolecular mechanisms of Fibrosis: Targets of Therapy. John P Iredale University of Edinburgh, UK
Molecular mechanisms of Fibrosis: Targets of Therapy John P Iredale University of Edinburgh, UK Take home messages: The wound healing MFBs of the liver and the hepatic macrophages are key players in progressive
More informationSupplemental Table 1. Primer sequences for transcript analysis
Supplemental Table 1. Primer sequences for transcript analysis Primer Sequence (5 3 ) Primer Sequence (5 3 ) Mmp2 Forward CCCGTGTGGCCCTC Mmp15 Forward CGGGGCTGGCT Reverse GCTCTCCCGGTTTC Reverse CCTGGTGTGCCTGCTC
More informationRath, N., and Olson, M. (2016) Regulation of pancreatic cancer aggressiveness by stromal stiffening. Nature Medicine, 22(5), pp. 462-463. There may be differences between this version and the published
More informationstem cell products Basement Membrane Matrix Products Rat Mesenchymal Stem Cell Growth and Differentiation Products
stem cell products Basement Membrane Matrix Products Rat Mesenchymal Stem Cell Growth and Differentiation Products Stem Cell Qualified Extracellular Matrix Proteins Stem cell research requires the finest
More informationMeeting Report. From December 8 to 11, 2012 at Atlanta, GA, U.S.A
Meeting Report Affiliation Department of Transfusion Medicine and Cell Therapy Name Hisayuki Yao Name of the meeting Period and venue Type of your presentation Title of your presentation The 54 th Annual
More informationTissue repair. (3&4 of 4)
Tissue repair (3&4 of 4) What will we discuss today: Regeneration in tissue repair Scar formation Cutaneous wound healing Pathologic aspects of repair Regeneration in tissue repair Labile tissues rapid
More informationInterface hepatitis in PBC: Prognostic marker and therapeutic target
Interface hepatitis in PBC: Prognostic marker and therapeutic target Raoul Poupon Service d Hépatologie, Hôpital Saint-Antoine, Paris Faculté de Médecine Pierre & Marie Curie, Paris Key features of
More informationHepaRG LX2. HepaRG HepaRG LX2 LX2
C Supporting Figure 1. Experimental design of s between and cells. (A) -hepatocytes were isolated from a 30 days of -progenitors. Differentiation into mature hepatocytes was achieved following a 2-weeks
More informationSUPPLEMENTARY INFORMATION
DOI: 10.1038/ncb2610 Figure S1 FSMCs derived from MSLN CLN transgenic mice express smooth muscle-specific proteins. Beta-galactosidase is ubiquitously expressed within cultured FSMCs derived from MSLN
More informationWHAT THE EXPERIMENTAL MODELS CAN TEACH US IN NAFLD/NASH? Claudio Tiribelli, MD PhD Scientific Director FIF
WHAT THE EXPERIMENTAL MODELS CAN TEACH US IN NAFLD/NASH? Claudio Tiribelli, MD PhD Scientific Director FIF ctliver@fegato.it Worldwide estimated prevalence of NAFLD distribution of PNPLA3 genotypes 2017-Younussi
More informationAdvances in Understanding Hepatic Fibrosis and Chronic Liver Disease
Advances in Understanding Hepatic Fibrosis and Chronic Liver Disease Scott Friedman, M.D. Fishberg Professor of Medicine Dean for Therapeutic Discovery Chief, Division of Liver Diseases Icahn School of
More informationRegulator of G-protein signaling 5 is expressed in hepatic stellate cells. and moderates the fibrotic response to injury. Arya J.
Regulator of G-protein signaling 5 is expressed in hepatic stellate cells and moderates the fibrotic response to injury Arya J. Bahrami A dissertation submitted in partial fulfillment of the requirements
More informationChapter 18 Liver and Gallbladder
Chapter 18 Liver and Gallbladder 解剖學科徐淑媛 本堂重點 1. Liver : functions & histology 2. Gallbladder Physiology Liver Produce circulating plasma proteins Vitamin Iron Degradation Metabolism Bile manufacture (exocrine)
More informationAntifibrotic therapy: between hopes and reality. Fabio Marra Dipartimento di Medicina Sperimentale e Clinica University of Florence, Italy
Antifibrotic therapy: between hopes and reality Fabio Marra Dipartimento di Medicina Sperimentale e Clinica University of Florence, Italy Disclosures Abbvie: consultant fees AstraZeneca: consultant fees
More informationRole of Inflammation in Pulmonary Hypertension
Role of Inflammation in Pulmonary Hypertension K. R. Stenmark University of Colorado Denver, USA Prominent Fibroproliferative Changes are Observed in the Lung Vasculature of Infants With Pulmonary Arterial
More informationConnective Tissue Response in IBD
Connective Tissue Response in IBD Dr I C Lawrance MB BS, PhD FRACP School of Medicine and Pharmacology, University of Western Australia, Fremantle Hospital Intestinal response to Chronic Inflammation Control
More informationSUPPLEMENTARY INFORMATION
doi:10.1038/nature10188 Supplementary Figure 1. Embryonic epicardial genes are down-regulated from midgestation stages and barely detectable post-natally. Real time qrt-pcr revealed a significant down-regulation
More informationStudy Design to Validate Biomarkers of Therapeutic Response in NASH Due to Cirrhosis
Study Design to Validate Biomarkers of Therapeutic Response in NASH Due to Cirrhosis Detlef Schuppan Institute of Translational Immunology and Research Center for Immune Therapy, University Medical Center
More informationHealing and Repair. Dr. Nabila Hamdi MD, PhD
Healing and Repair Dr. Nabila Hamdi MD, PhD 1 ILOs Know the classification of human cells according to their ability for proliferation. Understand the mechanism of cellular regeneration. Identify the types
More informationcontributes to reversal of biliary fibrosis by Popov et al.
Supplementary data to MS Macrophage-mediated phagocytosis of apoptotic cholangiocytes contributes to reversal of biliary fibrosis by Popov et al. Supplementary table 1. Primers and probes used in quantitative
More informationFOR REVIEW. BMB Reports - Manuscript Submission. Manuscript Draft. Manuscript Number: BMB
BMB Reports - Manuscript Submission Manuscript Draft Manuscript Number: BMB-18-095 Title: Insulin Receptor Substrate 2:A Bridge between Hippo and AKT Pathways Article Type: Perspective (Invited Only) Keywords:
More informationSupporting Information
Supporting Information Rock et al. 10.1073/pnas.1117988108 Fig. S1. Heterogeneity of stromal cells in normal and fibrotic mouse lungs. Sections of normal mouse lungs (A and D) and fibrotic lungs collected
More informationHepatic stellate cells (HSCs) are characterized
LIVER BIOLOGY/PATHOBIOLOGY Septum Transversum-Derived Mesothelium Gives Rise to Hepatic Stellate Cells and Perivascular Mesenchymal Cells in Developing Mouse Liver Kinji Asahina, 1 Bin Zhou, 2,3 William
More informationChronic variable stress activates hematopoietic stem cells
SUPPLEMENTARY INFORMATION Chronic variable stress activates hematopoietic stem cells Timo Heidt *, Hendrik B. Sager *, Gabriel Courties, Partha Dutta, Yoshiko Iwamoto, Alex Zaltsman, Constantin von zur
More informationOriginal Article mir-144 regulates transforming growth factor-β1 iduced hepatic stellate cell activation in human fibrotic liver
Int J Clin Exp Pathol 2015;8(4):3994-4000 www.ijcep.com /ISSN:1936-2625/IJCEP0006145 Original Article mir-144 regulates transforming growth factor-β1 iduced hepatic stellate cell activation in human fibrotic
More informationFoxm1 Transcription Factor is Required for Lung Fibrosis and Epithelial to Mesenchymal Transition.
Manuscript EMBO-2012-82682 Foxm1 Transcription Factor is Required for Lung Fibrosis and Epithelial to Mesenchymal Transition. David Balli, Vladimir Ustiyan, Yufang Zhang, I-Ching Wang, Alex J. Masino,
More informationAs outlined under External contributions (see appendix 7.1), the group of Prof. Gröne at the
3 RESULTS As outlined under External contributions (see appendix 7.1), the group of Prof. Gröne at the DKFZ in Heidelberg (Dept. of Cellular and Molecular pathology) contributed to this work by performing
More informationFour Types of Vertebrate Tissue
BIO 121 Molecular Cell Biology Lecture Section IV A. Cells in the Context of Tissue, Organ and Organismal Architecture B. Wound Healing Four Types of Vertebrate Tissue 1.Epithelium 2.Connective Tissue
More informationDistinct Roles Of CCN1 And CCN2 In Limb Development
Distinct Roles Of CCN1 And CCN2 In Limb Development Jie Jiang, PhD 1, Jessica Ong, BS 1, Faith Hall-Glenn, PhD 2, Teni Anbarchian, BS 1, Karen M. Lyons, PhD 1. 1 University of California, Los Angeles,
More informationSupplementary Figure 1 ITGB1 and ITGA11 increase with evidence for heterodimers following HSC activation. (a) Time course of rat HSC activation
Supplementary Figure 1 ITGB1 and ITGA11 increase with evidence for heterodimers following HSC activation. (a) Time course of rat HSC activation indicated by the detection of -SMA and COL1 (log scale).
More informationremoved replaced inflammation scar tissue
HOMEOSTASIS Normal maintenance and renewal of differentiated cells in many tissues This does NOT involve leukocytes. Leukocytes and inflammation occurs in response to damage NEED FOR REPAIR When tissue
More informationScleroderma. Chronic multisystemic disease characterized by vasculopathy, variable degree of inflammation, and fibrosis
Scleroderma Chronic multisystemic disease characterized by vasculopathy, variable degree of inflammation, and fibrosis Incidence 3.7-22.8 cases/million Female:male 5:1 Pulmonary fibrosis common, severe
More informationDo Histological Features Inform DILI mechanisms?
Do Histological Features Inform DILI mechanisms? Drug-Induced Liver Injury (DILI) Conference XVII June, 2017 David Kleiner, M.D., Ph.D. NCI/Laboratory of Pathology Disclosures No financial or other conflicts
More informationStimulating healthy tissue regeneration by targeting the 5-HT 2B receptor in chronic liver disease.
Stimulating healthy tissue regeneration by targeting the 5-HT 2B receptor in chronic liver disease. Mohammad R Ebrahimkhani, Fiona Oakley, Lindsay B Murphy, Jelena Mann, Anna Moles, Maria J Perugorria,
More informationNASH Bench to Bedside
NASH Bench to Bedside October 2006 Anna Mae Diehl, M.D. Gastroenterology Division Duke University NonAlcoholic Fatty Liver Disease Common ~1/4-1/3 1/3 US adults Outcome highly variable Course indolent
More informationMesenchymal progenitor cells in intramuscular connective tissue development
Mesenchymal progenitor cells in intramuscular connective tissue development Min Du, Ph.D. Professor and Endowed Chair Department of Animal Sciences Washington State University Pullman, WA Beef Quality:
More informationBile Acids and Liver Fibrosis Causative Agent and Therapeutic Tool
Bile Acids and Liver Fibrosis Causative Agent and Therapeutic Tool Peter Fickert, Andrea Fuchsbichler, Tarek Moustafa, Gernot Zollner, Emina Halilbasic, Ulrike Stöger, Cord Langner, Helmut Denk, and Michael
More informationDisclosures. Outline. Extracellular Vesicles in Fatty Liver Disease. From Contributors to disease pathogenesis to novel biomarkers
Extracellular Vesicles in Fatty Liver Disease From Contributors to disease pathogenesis to novel biomarkers Ariel Feldstein, M.D. Professor of Pediatrics Chief, Division of Pediatric Gastroenterology Hepatology
More informationCancer Biology Dynamical Cell Systems
The Institute of Cancer Research PHD STUDENTSHIP PROJECT PROPOSAL PROJECT DETAILS Project Title: SUPERVISORY TEAM Primary Supervisor: The forces behind pancreatic cancer; and changing them as a therapeutic
More informationLiver fibrosis represents a wound-healing process
Inhibition of Phosphatidylinositol 3-Kinase Signaling in Hepatic Stellate Cells Blocks the Progression of Hepatic Fibrosis Gakuhei Son, 1 Ian N. Hines, 1 Jeff Lindquist, 1 Laura W. Schrum, 2 and Richard
More informationLiver fibrosis: Twenty years after. Fabio Marra Dipartimento di Medicina Sperimentale e Clinica Università di Firenze
Liver fibrosis: Twenty years after Fabio Marra Dipartimento di Medicina Sperimentale e Clinica Università di Firenze fabio.marra@unifi.it DISCLOSURES: Grants from: ViiV Healthcare Consultant for: Bayer
More informationParacrine Mechanisms in Adult Stem Cell Signaling and Therapy
Paracrine Mechanisms in Adult Stem Cell Signaling and Therapy Massimiliano Gnecchi, Zhiping Zhang, Aiguo Ni, Victor J. Dzau Circulation Research 2008 Nov 21;103(11):1204-19 Introduction(1) After AMI all
More informationModels of liver fibrosis: exploring the dynamic nature of inflammation and repair in a solid organ
Review series Models of liver fibrosis: exploring the dynamic nature of inflammation and repair in a solid organ John P. Iredale Medical Research Council/University of Edinburgh Centre for Inflammation
More informationFibrosis is a highly conserved response to hepatic
NEW HORIZONS Hepatic Inflammation and Fibrosis: Functional Links and Key Pathways Ekihiro Seki 1,2 and Robert F. Schwabe 3,4 Inflammation is one of the most characteristic features of chronic liver disease
More informationExploring a Link Between Spy1 and Hepatocellular Carcinoma Progression
University of Windsor Scholarship at UWindsor UWill Discover Undergraduate Conference UWill Discover 2016 Mar 29th, 4:00 PM - 5:00 PM Exploring a Link Between Spy1 and Hepatocellular Carcinoma Progression
More informationAnalysis on the mechanism of reduced nephron number and the pathological progression of chronic renal failure in Astrin deficient rats
Analysis on the mechanism of reduced nephron number and the pathological progression of chronic renal failure in Astrin deficient rats Summary of Doctoral Thesis Hidenori Yasuda Graduate School of Veterinary
More informationCirrhosis is different from Fibrosis
Riunione Monotematica AISF 2016 «The Future of Liver Disease: Beyond HCV is there a Role for Hepatologist» Milan 13 th -14 th 2016 Cirrhosis is different from Fibrosis I have not disclosures to declare
More informationMyofibroblastic transformation of rat hepatic stellate cells: the role of Notch signaling and epithelial-mesenchymal transition regulation
European Review for Medical and Pharmacological Sciences Myofibroblastic transformation of rat hepatic stellate cells: the role of Notch signaling and epithelial-mesenchymal transition regulation Q.-D.
More informationQuantitative Imaging Goals for NIDDK
Quantitative Imaging Goals for NIDDK Maren R. Laughlin Senior Advisor Quantitative Imaging Goals for NIDDK Monitor progression and response to therapy of disease in liver kidney and urological organs bone
More informationHepatic Stellate Cells and Liver Fibrosis
Juan E. Puche, 1,2 Yedidya Saiman, 1 and Scott L. Friedman *1 ABSTRACT Hepatic stellate cells are resident perisinusoidal cells distributed throughout the liver, with a remarkable range of functions in
More informationRegenerative Tissue Matrix in Treatment of Wounds
Regenerative Tissue Matrix in Treatment of Wounds Learning Objectives Differentiate between reparative and regenerative healing Review surgical techniques for applying a regenerative tissue scaffold to
More informationI TESSUTI: Dott.ssa Liliana Belgioia Università degli Studi di Genova
I TESSUTI: 1. Repair, Radiosensitivity, Recruitment, Repopulation, Reoxygenation 2. Acute and chronic hypoxia 3. Tissue microenvironment and tissue organization Dott.ssa Liliana Belgioia Università degli
More informationLIVER & SPLEEN. Color index: Slides.. Important..Notes..Extra..
LIVER & SPLEEN Color index: Slides.. Important..Notes..Extra.. Objectives: By the end of this lecture, the student should be able to describe: 1. The histological structure of liver with special emphasis
More informationRole of Stem Cell in Chronic Liver Disease
KASL 2014 Role of Stem Cell in Chronic Liver Disease Ja Kyung Kim, MD, PhD Dept. of Internal Medicine, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Korea Liver Cirrhosis Clinical
More informationInterleukin-20 is associated with delayed healing in diabetic wounds
Interleukin-20 is associated with delayed healing in diabetic wounds Phillip Finley, PhD Integrated and Applied Sciences Program Biology and Statistics/Research Methodology Normal Healing Body s natural
More informationIndex. Note: Page numbers of article titles are in boldface type.
Note: Page numbers of article titles are in boldface type. A Abetalipoproteinemia NASH and, 537 Acquired errors of metabolism NASH and, 536 537 Amiodarone steatohepatitis due to, 527 Anticonvulsant mood
More informationSupplementary Figure 1 Chemokine and chemokine receptor expression during muscle regeneration (a) Analysis of CR3CR1 mrna expression by real time-pcr
Supplementary Figure 1 Chemokine and chemokine receptor expression during muscle regeneration (a) Analysis of CR3CR1 mrna expression by real time-pcr at day 0, 1, 4, 10 and 21 post- muscle injury. (b)
More informationJournal Club Semmler Lorenz
Beer et al. 2015 - Analysis of the Secretome of Apoptotic Peripheral Blood Mononuclear Cells: Impact of Released Proteins and Exosomes for Tissue Regeneration Journal Club 13.11.2017 1 Introduction to
More informationTenogenic Differentiation of Mesenchymal Stem Cells and Their Applications in Tendon Tissue Engineering
Tenogenic Differentiation of Mesenchymal Stem Cells and Their Applications in Tendon Tissue Engineering Professor Gang Li, MBBS, D Phil (Oxon) Department of Orthopaedics and Traumatology, The Chinese University
More information1 st TMDU-UCSD-USC Joint Symposium Wednesday, September 5, 2018
1 st TMDU-UCSD-USC Joint Symposium Wednesday, September 5, 2018 FRONTIERS IN LIVER RESEARCH AND GLOBAL MEDICINE PROGRAM & ABSTRACT BOOK Hosted by Tokyo Medical and Dental University Institute of Global
More informationHematopoiesis. - Process of generation of mature blood cells. - Daily turnover of blood cells (70 kg human)
Hematopoiesis - Process of generation of mature blood cells - Daily turnover of blood cells (70 kg human) 1,000,000,000,000 total cells 200,000,000,000 red blood cells 70,000,000,000 neutrophils Hematopoiesis
More informationPrimary biliary cirrhosis (PBC) is a chronic cholestatic
RAPID COMMUNICATION Bile Ductules and Stromal Cells Express Hedgehog Ligands and/or Hedgehog Target Genes in Primary Biliary Cirrhosis Youngmi Jung, 1 Shannon J. McCall, 2 Yin-Xiong Li, 1 and Anna Mae
More informationExtracellular vesicles and ceramide: new mediators for macrophage chemotaxis? Natalie J. Torok
Extracellular vesicles and ceramide: new mediators for macrophage chemotaxis? Natalie J. Torok Department of Medicine, Gastroenterology and Hepatology, UC Davis, Sacramento, CA, and Northern California
More informationAnimal Tissue Culture SQG 3242 Biology of Cultured Cells. Dr. Siti Pauliena Mohd Bohari
Animal Tissue Culture SQG 3242 Biology of Cultured Cells Dr. Siti Pauliena Mohd Bohari The Culture Environment Changes of Cell s microenvironment needed that favor the spreading, migration, and proliferation
More informationHepatic stellate cells in liver development, regeneration, and cancer
Review series Hepatic stellate cells in liver development, regeneration, and cancer Chunyue Yin, 1 Kimberley J. Evason, 2 Kinji Asahina, 3 and Didier Y.R. Stainier 1 1 Department of Biochemistry and Biophysics,
More informationCD34+ Cells: A Comparison of Stem and Progenitor Cells in Cord Blood, Peripheral Blood, and the Bone Marrow
White Paper September 2016 CD34+ Cells: A Comparison of Stem and Progenitor Cells in Cord Blood, Peripheral Blood, and the Bone Marrow Lily C. Trajman, PhD Introduction: Hematopoietic Stem Cells (HSCs)
More informationAAO Foundation Awards Final Report
401 N. Lindbergh Blvd. St. Louis, MO 63141 Tel.: 314.993.1700, #546 Toll Free: 800.424.2841, #546 Fax: 800.708.1364 Cell: 314.283.1983 E-Mail: rhazel@aaortho.org AAO Foundation Awards Final Report In an
More informationPathogenesis and treatment of hepatic fibrosis: is cirrhosis reversible?
Clinical Medicine 2011, Vol 11, No 2: 179 83 Pathogenesis and treatment of hepatic fibrosis: is cirrhosis reversible? Jonathan Fallowfield, Academy of Medical Sciences/Health Foundation clinician scientist
More informationMS/MS analysis of plasma from AD patients and healthy volunteers (n=8 healthy volunteers
Figure S. PGFα, - and -HETE are elevated in of patients with Acute Decompensation (AD) when compared with healthy volunteers. (a-g) Lipidomic LC/ESI- MS/MS analysis of from AD patients and healthy volunteers
More informationBrief Overview of Tissues STUDENT NOTES Date: 1. Tissue 2. Connective Tissue. 3. Tissue 4. Nervous Tissue
Levels of Structural Organization: Brief Overview of Tissues STUDENT NOTES Date: Recall The four major tissue types include: 1. Tissue 2. Connective Tissue 3. Tissue 4. Nervous Tissue Epithelial Tissue
More informationRegenerative Medicine for Sclerotic Disorders
Regenerative Medicine Regenerative Medicine for Sclerotic Disorders JMAJ 7(7): 3 37, Toshikazu NAKAMURA rofessor, Division of Molecular Regenerative Medicine, Course of Advanced Medicine, Osaka University
More informationRepair-associated inflammation in nonalcoholic fatty liver disease
LINACRE LECTURE Clinical Medicine 2013, Vol 13, No 6: s15 s19 Repair-associated inflammation in nonalcoholic fatty liver disease Wing-Kin Syn ABSTRACT The mechanisms that drive non-alcoholic fatty liver
More informationMark D Gorrell Sumaiya Chowdhury, Fiona Keane, Stephen Twigg, Geoff McCaughan
The protease fibroblast activation protein [FAP] as a biomarker and therapeutic target in chronic liver injury Mark D Gorrell Sumaiya Chowdhury, Fiona Keane, Stephen Twigg, Geoff McCaughan A.W. Morrow
More informationConstruction of Nephron by Fusion of Adult Glomeruli to Ureteric Buds with Type V Collagen. Yusuke Murasawa, Pi-chao Wang
Construction of Nephron by Fusion of Adult Glomeruli to Ureteric Buds with Type V Collagen Yusuke Murasawa, Pi-chao Wang Abstract Although tissue engineering of artificial organs such as skin or cartilage
More informationHepatogenesis I Liver development
Hepatogenesis I Liver development HB 308 George Yeoh Room 2.59 MCS Building yeoh@cyllene.uwa.edu.au Topics Early liver development Tissue interaction - role of morphogens and cytokines Liver enriched transcription
More informationEuropean Respiratory Society Annual Congress. Presented at: of new drugs for respiratory diseases. Barcelona, Spain, September 7-11, 2013 Page 1
PBI-4050, a novel first-in-class anti-fibrotic compound, reduces lung fibrosis in the bleomycin-induced lung fibrosis model: a comparative study with pirfenidone Presented at: Thematic Poster Session:
More informationAn Update on the Pharmacological Treatment of Nonalcoholic Fatty Liver Disease: Beyond Lifestyle Modifications
REVIEW An Update on the Pharmacological Treatment of Nonalcoholic Fatty Liver Disease: Beyond Lifestyle Modifications Naim Alkhouri, M.D.,*, and Andrea Scott, B.S.* Nonalcoholic fatty liver disease (NAFLD)
More informationReview Series Stem Cell Research
Q J Med 2014; 107:417 421 doi:10.1093/qjmed/hcu013 Advance Access Publication 22 January 2014 Review Series Stem Cell Research Stem cells for liver regeneration N.N. THAN and P.N. NEWSOME From the Centre
More informationSupplementary Figure 1: Lgr5 expression in liver was induced by CCL4 and decreased after liver recovery. Mice were treated with single dose of CCL4
Supplementary Figure 1: Lgr5 expression in liver was induced by CCL4 and decreased after liver recovery. Mice were treated with single dose of CCL4 or control oil, the livers were collected at various
More informationBody Tissues. Cells are specialized for particular functions Tissues - groups of cells with similar structure. and function Four primary tissue types:
Chapter 3 Tissues Body Tissues Cells are specialized for particular functions Tissues - groups of cells with similar structure and function Four primary tissue types: Epithelium Connective tissue Nervous
More informationTissue factor-par2 signaling promotes diet-induced obesity and adipose
Supplementary figures for Tissue factor-par2 signaling promotes diet-induced obesity and adipose inflammation. Leylla Badeanlou 1, Christian Furlan-Freguia 2, Guang Yang 1, Wolfram Ruf 2,3, and Fahumiya
More informationMost abundant and widely distributed tissues in the body Binds, support, and strengthen body tissues, protect and insulate internal organ, serve as
Connective tissue Most abundant and widely distributed tissues in the body Binds, support, and strengthen body tissues, protect and insulate internal organ, serve as major transport system, compartmentalizes
More informationMouse Models of K-RAS- and B-RAFinduced
Mouse Models of K-RAS- and B-RAFinduced Cancer Martin O. Bergö, Professor Sahlgrenska Cancer Center University of Gothenburg www.gu.se Why models? Why mice? Critical to understanding pathogenesis and identifying
More informationMario Strazzabosco MD, PhD
Mario Strazzabosco MD, PhD Professor of Medicine & Gastroenterology Deputy Director, Yale Liver Center, Director, Hepatobiliary Cancer Program Yale University School of Medicine Director Master Program
More information